NetApp Joins Aston Martin Cognizant Formula One Team to Pioneer Data-Driven Racing Strategy
1.3.2021 16:00:00 EET | Business Wire | Press release
NetApp® (NASDAQ: NTAP), a global cloud-led, data-centric software company, and Aston Martin Cognizant Formula One™ today announced a multi-year partnership as the world-famous car company gears up for its return to Formula One competition. After more than 60 years away, the British car brand returns to the F1™ grid, supported by NetApp, with a new edge: an innovative approach to racing utilizing the power of data.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210301005160/en/
NetApp Joins Aston Martin Cognizant Formula One Team to Pioneer Data-Driven Racing Strategy (Graphic: Business Wire)
The partnership with NetApp reinforces Aston Martin Cognizant Formula One Team’s commitment to unlocking the very best of cloud by outfitting the team with world-class data and cloud services. Broad and ambitious in scope, the partnership will focus on maximizing performance both on and off the track.
From trackside to factory to cloud, the data used to inform Aston Martin Cognizant Formula One Team’s racing strategies will be available in real time on a global scale. With a data fabric powered by NetApp, the team will be able to extract more value from their data to better gauge car performance and address necessary refinements before, during, and after each race.
This data fabric will also help reduce operational complexities, while ensuring data compliance, security, and protection of the team’s intellectual property. By standardizing on NetApp across all platforms, the British racing team will be able to maximize resource utilization and remove inefficient data silos, enabling costly IT investments to be diverted back into car and team development.
“We are thrilled to partner with Aston Martin Cognizant Formula One as it embarks on a highly ambitious data journey in pursuit of greater speed, higher reliability and unmatched efficiency,” said James Whitemore, chief marketing officer at NetApp. “By tapping into our 28 years of data-centric innovation, we are proudly supporting the team as they push the boundaries of continuous performance improvement beyond the finish line.”
“Formula One teams have always been pioneers in analyzing data for a competitive advantage, especially when milliseconds mean the difference between pole position and starting somewhere in the middle of the pack,” said Otmar Szafnauer, chief executive officer and team principal at Aston Martin Cognizant Formula One. “The team’s partnership with NetApp, along with title partner Cognizant, represents a new stage in our journey of continuous improvement. We are excited to introduce NetApp as we strive to make everything we do faster and smarter. By empowering our brilliant team of people with NetApp’s industry-leading data solutions, we are ushering in a new era of racing where we can constantly evolve to be a faster, smarter and more exciting team.”
About NetApp
NetApp is a global cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.
About Aston Martin Cognizant Formula One Team
After more than 60 years away from Formula One, Aston Martin returns to Grand Prix racing in 2021. With one of the most iconic emblems in the world above the garages and a team of almost 500 passionate men and women at its heart, this is a team with both a rich heritage and a fresh perspective – bringing new energy to the sport with a determination to shake up the order and compete at the sharp end.
Our mission is to use the global platform of motorsport to engage a new wave of fans – showcasing the technology and innovation which live at our core while representing the values that resonate with the changing world in which we live.
The new age of Aston Martin Cognizant Formula One Team begins here.
www.astonmartinf1.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210301005160/en/
Contact information
NetApp
Media Contact:
Chris Drago
NetApp
1 (831) 900-8889
chris.drago@netapp.com
NetApp Investor Contact:
Lance Berger
NetApp
1 (408) 822-6628
lance.berger@netapp.com
Aston Martin Cognizant Formula One Team Media Contacts:
Matt Bishop
Chief Communications Officer
+44 7976 835878
Matt.Bishop@astonmartinf1.com
Will Hings
Head of Media & Communications
+44 7734 202020
Will.Hings@astonmartinf1.com
Joanne Revill
Senior Media Officer
+ 44 7408 901384
Joanne.Revill@astonmartinf1.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom